Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

New data from the Phase 3 RAPID clinical trial of etripamil, an investigational calcium channel blocker nasal spray, showed positive results in converting paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm in the at-home setting. The presentation was featured during a late-breaking clinical trials session at the American Heart Association (AHA) 2022 Scientific Sessions. #AHA22

Nasal spray for paroxysmal supraventricular tachycardia enters US market

New drug allows patients to self-treat PSVT. About 2 million people in the U.S. have been diagnosed with condition.

Men developed CVD earlier than women, according to 35-year CARDIA study

Promoting preventive care among young adult men during critical periods of their life may be the key to reducing rates of cardiovascular disease. 

CABG coronary artery bypass grafting heart surgery

Comparable long-term survival seen in two common CABG strategies

STS late-breaking study found BITA and SITA+RA have similar long-term survival, but age plays a role in which to choose.

artificial intelligence healthcare industry

Lawsuits filed over allegations of dirty surgical tools, patient infections and defamation

A surgeon and a medical device representative accuse Portneuf Medical Center of failing to address an ongoing problem with contaminated surgical tools that left patients with serious infections.

Valcare Medical’s Amend Transseptal System for mitral regurgitation

Interventional cardiologists implant new-look heart device for first time in US

The Amend device from Valcare Medical has a closed ring shape similar to the annuloplasty rings used to treat MR during open-heart surgeries. These early patients will be followed for a total of five years.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

IVL may be safer than atherectomy in patients with severely calcified lesions

Researchers explored data from more than 1,000 patients with calcified coronary artery disease who required plaque modification. IVL and atherectomy were linked to comparable success rates, but adverse events were less likely with IVL.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

Cardiologists should always be involved when heart issues arise after surgery

Cardiac complications after noncardiac surgeries are a significant concern, especially as patients keep living longer and surgical volumes continue to rise.

Thumbnail

Russia rolls out MosMed.AI to standardize healthcare AI nationwide

Initiatives include radiology image reading, data analytics, remote patient monitoring, speech recognition and more. Most of the federation has adopted the standards of the artificial intelligence platform.